To qualify an alternative plasticizer for food-contact flexible PVC, buyers should first confirm that the exact substance and supplier grade are permitted for the intended market, food type, contact time, and temperature; then compare the candidate with the incumbent at both equal phr and matched flexibility. DEHT/DOTP, DINCH, TOTM, ATBC, DOA/DEHA, and ESBO cannot share one approval path because their plasticizing efficiency, fusion behavior, migration, extraction, volatility, and functional role differ. A COA or “phthalate-free” declaration can support screening but cannot prove finished-article compliance or performance. The next step should be controlled sample evaluation against predefined formulation, migration, and processing acceptance criteria.

Start With the Intended Food-Contact Use

“Non-phthalate” describes what a candidate is not. It does not establish where, how, or by whom the material may be supplied and used.

The qualification boundary should identify:

• target market, such as the United States or European Union;
• single-use or repeated-use article;
• food types, including whether fatty-food contact is expected;
• maximum contact time and temperature;
• maximum plasticizer concentration in the PVC;
• article thickness and surface-area-to-food-volume relationship;
• exclusions involving infant formula, human milk, or foods intended for infants;
• exact manufacturer, supplier, grade, and regulatory basis.

This distinction has become more important following the FDA’s May 2026 scientific evaluation of eight ortho-phthalates authorized as food-contact plasticizers. The evaluation supported grouping DEHP, DCHP, DIOP, and DINP for a possible future cumulative risk assessment, but it did not prohibit all remaining phthalates or automatically authorize their alternatives. The FDA phthalates evaluation should therefore trigger a review of existing material approvals—not a blanket substitution decision.

In the United States, an effective Food Contact Notification may also be manufacturer- or supplier-specific. For example, FDA FCN No. 2468 covers DEHT/DOTP, CAS 6422-86-2, supplied by the identified manufacturer for specified applications. Its PVC use is limited to repeated-use articles, a maximum concentration of 55% by weight in the finished plasticized PVC formulation, food-contact temperatures not exceeding 100°C, and excludes contact with infant formula and human milk.

That notification cannot be used to conclude that every DEHT/DOTP grade from every supplier has the same U.S. regulatory coverage.

Which Alternative Plasticizer Families Should Be Screened?

Candidate selection should start from the function required in the food-contact PVC article. The following families may enter screening, but their qualification evidence is not interchangeable.

TOTM illustrates why the chemical name alone is insufficient. Commission Regulation (EU) 2023/1442 added TOTM as FCM No. 1078 for use as a plasticizer in soft PVC, with a specific migration limit of 1 mg/kg food and an exclusion for contact with foods intended for infants. The official EU regulation supports that defined use; it does not establish unrestricted approval for every food-contact condition or every finished article.

The same use-specific review is required for DEHT/DOTP, DINCH, ATBC, DOA/DEHA, and ESBO. A candidate should not enter laboratory evaluation until the buyer can identify a plausible regulatory pathway for the exact supplier grade and intended use.

Compare at Equal phr and Matched Flexibility

One comparison condition cannot answer every qualification question.

Testing the incumbent and candidate at the same parts per hundred resin shows whether their plasticizing efficiencies differ. Testing only at equal phr, however, can make secondary properties difficult to interpret when the resulting hardness or modulus is not equivalent.

A stronger comparison uses two stages:

1. Equal-phr comparison: Keep PVC resin, stabilizer, filler, processing sequence, and plasticizer dosage constant. Measure the difference in hardness, modulus, fusion, tensile properties, elongation, color, and processing behavior.
2. Matched-flexibility comparison: Adjust the candidate dosage to reproduce the incumbent’s target hardness or modulus. Then compare migration, extraction, mechanical retention, thermal aging, and processing robustness.

The two stages answer different questions:

• Equal phr asks, “Does the candidate provide the same plasticizing efficiency?”
• Matched flexibility asks, “Once the required flexibility is achieved, does the candidate create another unacceptable risk?”

A candidate requiring a modest, controlled dosage adjustment may still be acceptable. A candidate requiring changes to the PVC resin, stabilizer system, filler, processing temperature, and multiple formulation components is a reformulation candidate—not a drop-in alternative.

ChemicalCell’s second-source functional additive qualification framework provides a broader incumbent-versus-candidate structure for distinguishing equivalent performance from reformulation.

Which Evidence Can Be Compared Directly?

Hardness data, for example, may change with specimen thickness, conditioning time, temperature, formulation, and method. Migration data may change with food simulant, contact temperature, duration, plasticizer loading, article thickness, surface-area-to-volume ratio, and the analytical reporting unit.

A lower migration value is meaningful only when those conditions are comparable. Otherwise, the difference may reflect the test design rather than the material.

What Should Restricted-Phthalate Evidence Include?

A “phthalate-free” supplier declaration is preliminary evidence. Before using it for approval, buyers should confirm:

• the individual phthalates included in the scope;
• whether the requirement applies to the neat plasticizer, PVC compound, or finished article;
• sample preparation and extraction conditions;
• analytical technique and calibration approach;
• LOD or LOQ for each target substance;
• reporting basis and units;
• batch number and relationship to the proposed commercial supply.

This matters because a declaration may cover only a short customer list, while the applicable market requirement may include additional ortho-phthalates. It may also report “not detected” without showing whether the method can measure below the required limit.

A candidate should not be rejected simply because two laboratories report different numerical values. The buyer should first determine whether the methods, extraction efficiencies, analyte scopes, and LOQs are comparable.

What Can the COA Prove?

A COA can prove that one tested batch met the supplier’s release specification. It cannot prove that the material is authorized for the intended food-contact use, performs equivalently in the buyer’s PVC formulation, or meets migration requirements in the finished article.

For DEHT/DOTP, DINCH, TOTM, ATBC, and DOA/DEHA, useful release controls may include:

• identity or composition;
• assay or ester-content basis where applicable;
• acid value;
• water;
• color;
• density or viscosity where linked to process consistency;
• named process-related impurities where relevant.

ESBO requires a different specification logic. Epoxy or oxirane oxygen, iodine value, acidity, moisture, color, and vegetable-oil feedstock consistency may be more important than applying a conventional ester-plasticizer specification.

The specification should control only parameters that have a credible connection to regulatory identity, migration, PVC processing, stability, or batch consistency. Generic trace-metal or particle limits should not be copied into every plasticizer specification without an application-related reason.

The product specification, COA, TDS, SDS, regulatory statement, restricted-phthalate report, and sample label must describe the same grade and manufacturer. ChemicalCell’s guide to cross-checking COAs, TDSs, SDSs, and impurity profiles explains how document inconsistencies can expose identity, method, specification, or traceability gaps.

When Is a Supplier Sample Not Enough?

An R&D sample can establish whether the candidate deserves further evaluation. It cannot establish that commercial supply is approved.

Commercial-lot verification is required when the supplier sample is not produced through the routine commercial process or when scale can change:

• composition or impurity distribution;
• residual acidity or moisture;
• color and thermal stability;
• production mixing, fusion, shear or residence time;
• finished-article thickness;
• migration or extraction behavior;
• delivery packaging and contamination exposure.

For food-contact flexible PVC, testing the neat plasticizer alone is insufficient when the release decision depends on migration from the finished article. The approved PVC formulation, maximum intended loading, representative thickness, and worst intended contact conditions should be reflected in the migration evidence.

Approve, Conditionally Approve, or Do Not Approve?

Advance to Controlled Sample Evaluation

Advance the candidate when:

• the exact substance, supplier grade and regulatory pathway are identified;
• the authorization or regulatory basis matches the intended market and use;
• the specification and sample COA describe the same material;
• restricted-phthalate evidence has a defined scope and LOQ;
• the supplier can provide a traceable representative sample;
• application tests and acceptance criteria are agreed before testing.

This decision releases the material to evaluation. It is not final supplier approval.

Conditional Approval

Conditional approval may be appropriate when:

• the candidate passes at a documented adjusted dosage;
• a manageable processing change is required;
• finished-article performance is acceptable;
• commercial-lot confirmation remains pending;
• the remaining limitation is clearly recorded in the material specification or qualification plan.

The material should not be described as fully interchangeable if a source switch requires operators to change dosage or processing conditions.

Do Not Approve

Do not approve when:

• the regulatory basis does not cover the supplier, grade, market or intended conditions;
• substance identity or composition is unclear;
• migration evidence uses irrelevant simulants, time or temperature;
• “phthalate-free” evidence lacks an analyte list or suitable LOQ;
• the sample cannot be traced to the proposed commercial process;
• acceptable performance requires extensive unqualified reformulation;
• the supplier cannot define commercial specifications or change-control obligations.

Which Changes Require Requalification?

Supplier-side changes requiring review may include:

• manufacturer or supplier change where regulatory coverage is party-specific;
• manufacturing-site transfer;
• change in acid, alcohol, vegetable-oil or other key feedstock;
• catalyst, esterification, epoxidation, purification or finishing-process change;
• composition, additive, stabilizer or isomer-range change;
• expansion of acid value, water, color, assay or other critical limits;
• revised restricted-phthalate method, analyte list or LOQ;
• drum, IBC liner or bulk-delivery system change;
• unexplained commercial-lot migration or application shift.

Buyer-side changes can also invalidate the original qualification. Requalification should be considered when the PVC resin, stabilizer, filler, plasticizer loading, article thickness, production process, food type, contact time, temperature, target market, or intended reuse condition changes.

The extent of requalification should follow the affected risk. A test-method clarification may require data bridging; a new supplier-specific regulatory basis or new food-contact condition may require a complete regulatory and migration review.

What Should Be Included in the Sample Evaluation RFQ?

Buyers should submit the worst intended food-contact condition rather than requesting a generic “food-grade plasticizer.” Where multiple applications exist, each materially different food type, temperature, duration, article thickness, or reuse condition should be identified before the sample plan is finalized.

Once the intended use, incumbent comparison, acceptance criteria, regulatory evidence, and sample quantity are defined, buyers can submit them through the ChemicalCell RFQ form to request the corresponding specification, documentation, representative sample, and quotation.

The approval chain should remain continuous:

exact food-contact use → supplier-specific regulatory coverage → material-family screening → equal-phr and matched-flexibility comparison → finished-article migration → commercial-lot confirmation → controlled long-term supply.